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Purpose: The effects of carnitine depletion upon exercise performance and skeletal
muscle mitochondrial function remain largely unexplored. We therefore investigated the
effect of N-trimethyl-hydrazine-3-propionate (THP), a carnitine analog inhibiting carnitine
biosynthesis and renal carnitine reabsorption, on physical performance and skeletal
muscle mitochondrial function in rats.
Methods: Male Sprague Dawley rats were treated daily with water (control rats; n = 12)
or with 20mg/100 g body weight THP (n = 12) via oral gavage for 3 weeks. Following
treatment, half of the animals of each group performed an exercise test until exhaustion.
Results: Distance covered and exercise performance were lower in THP-treated
compared to control rats. In the oxidative soleus muscle, carnitine depletion caused
atrophy (–24%) and impaired function of complex II and IV of the mitochondrial electron
transport chain. The free radical leak (ROS production relative to oxygen consumption)
was increased and the cellular glutathione pool decreased. Moreover, mRNA expression
of markers of mitochondrial biogenesis and mitochondrial DNA were decreased in
THP-treated compared to control rats. In comparison, in the glycolytic gastrocnemius
muscle, carnitine depletion was associated with impaired function of complex IV
and increased free radical leak, whilst muscle weight and cellular glutathione pool
were maintained. Markers of mitochondrial proliferation and mitochondrial DNA were
unaffected.
Conclusions: Carnitine deficiency is associated with impaired exercise capacity in rats
treated with THP. THP-induced carnitine deficiency is associated with impaired function
of the electron transport chain in oxidative and glycolytic muscle as well as with atrophy
and decreased mitochondrial DNA in oxidative muscle.
Keywords: N-trimethyl-hydrazine-3-propionate, carnitine deficiency, exhaustive exercise, skeletal muscle,
mitochondria, reactive oxygen species
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INTRODUCTION
Carnitine, 4-trimethylamino-3-hydroxy butyric acid, is present
in all mammalian tissues and is ingested by the diet or produced
by endogenous biosynthesis from trimethyllysine (Bremer, 1983;
Hoppel and Davis, 1986; Vaz and Wanders, 2002). The major
carnitine body pool, accounting for >95% of the total body
stores, is located in skeletal muscle (Hoppel and Davis, 1986;
Krähenbühl et al., 2000; Spaniol et al., 2001). Carnitine is an
obligatory intermediate for the transport of long chain fatty
acids across this inner mitochondrial membrane and plays an
essential role in cellular energy metabolism due to acylation
of its β-hydroxyl group (Fritz and Mc, 1959; Bremer, 1983).
Furthermore, carnitine is important for buffering the free
pool of coenzyme A (CoASH). For instance, carnitine affects
carbohydrate metabolism by stimulating glucose oxidation
via reversing the inhibition of pyruvate dehydrogenase by
accumulating acetyl-CoA (Roberts et al., 2002; Wall et al., 2011).
Moreover, carnitine shifts the acyl-CoA to CoA-SH ratio in the
direction of CoASH and is thereby involved in trapping acyl
residues from peroxisomes andmitochondria (Brass and Hoppel,
1980; Friolet et al., 1994).
Low carnitine body stores can be primary as an inherited
defect of the main carnitine transporter OCTN2 (Organic
Cation/Carnitine Transporter 2) or secondary as a result of
an excessive renal loss or diminished supply of carnitine
and carnitine precursors. Primary carnitine deficiency is a
genetic disorder of the cellular carnitine-transporter system
associated with mutations in OCTN2 (Treem et al., 1988), a
sodium-dependent, high affinity carnitine carrier with a high
expression and activity in the renal proximal tubule (Nezu
et al., 1999). Secondary carnitine deficiency is associated with
reduced consumption of carnitine and carnitine precursors,
e.g., in vegetarians (Stephens et al., 2011; Novakova et al.,
2015), increased renal excretion of carnitine and acylcarnitines
in patients with organic acidurias (Roe et al., 1984) or
patients treated with drugs producing acyl-groups (Brass et al.,
2003; Morand et al., 2012), or in patients on hemodialysis
which removes carnitine from the circulation (Hiatt et al.,
1992; Evans et al., 2000). Muscle carnitine deficiency, which
can be a consequence of primary and secondary forms of
carnitine deficiency, is associated with muscle weakness and
fatigue (Treem et al., 1988; Hiatt et al., 1992), and possibly
cardiomyopathy (Zaugg et al., 2003). A low muscle carnitine
content is associated with impaired transport of long-chain
fatty acids into the mitochondrial matrix and therefore reduced
β-oxidation and accumulation of potentially toxic free fatty acids
and acyl-CoAs (Bremer, 1983).
N-trimethyl-hydrazine-3-propionate (THP or mildronate) is
a carnitine analog that has been used in certain countries as
a cardioprotective agent. This compound was used to generate
and characterize a rat model with secondary carnitine deficiency
Abbreviations: FRL, Mitochondrial Free Radical Leak; GSH, Reduced
glutathione; Nrf-2, Nuclear factor erythroid 2–related factor 2; OCTN2,
Organic Cation/Carnitine Transporter 2; PGC, Peroxisome proliferator-activated
receptor gamma coactivator; SOD, Superoxide dismutase; TFAm, Mitochondrial
transcription factor A; THP, N-trimethyl-hydrazine-3-propionate.
due to inhibition of OCTN2 and γ-butyrobetaine hydroxylase,
the last enzyme of the carnitine biosynthesis pathway (Vaz and
Wanders, 2002). THP treatment of rats for 2–3 weeks has been
shown to reduce the carnitine content of liver, heart, plasma, and
skeletal muscle by 70–80% (Spaniol et al., 2001). This decrease in
the carnitine content was associated with liver steatosis (Spaniol
et al., 2003), impaired myocardial function (Zaugg et al., 2003),
and impaired contractile force of the extensor digitorum longus
and atrophy of the soleus muscle in rats (Roberts et al., 2015).
While it is clear that THP-treated animals with secondary
carnitine deficiency have an impaired contractile function of
specific muscles (Roberts et al., 2015), it is currently unclear,
whether this impairs the exercise capacity of these rats.
Furthermore, it is currently also not known whether carnitine
deficiency affects mitochondrial function and/or mitochondrial
biogenesis. In athletes, long-term treatment with high oral doses
of carnitine was associated with improved exercise capacity and
mitochondrial function (Huertas et al., 1992).
Regarding the established effects of carnitine on skeletal
muscle energy metabolism (Stephens et al., 2007), and the
currently available data in THP rats (Roberts et al., 2015), we
hypothesized that rats with THP-induced secondary carnitine
deficiency may have an impaired exercise capacity and impaired
skeletal muscle mitochondrial function. In the present study,
we therefore performed an exhaustive exercise test (in order to
test mainly the buffer function of carnitine) in rats treated with
THP and examined mitochondrial function in two functionally
different muscle groups, the oxidative soleus and the glycolytic
gastrocnemius muscles. The main aim of the study was to
improve our knowledge about the consequences of secondary
carnitine deficiency on skeletal muscle function and physical
performance.
MATERIALS AND METHODS
Ethical Approval
In vivo experiments were performed in accordance with the
National Institute of Health guide for the care and use of
Laboratory animals (NIH Publication No. 8023, revised 1978),
and were approved by the Cantonal Veterinary Department
of Basel, Switzerland (License 1745). 24 male Sprague Dawley
rats, weighing ∼250 g (6 weeks), were obtained from Janvier
Labs (Saint-Berthevin, France), and were acclimatized to the
laboratory 1 week prior to the start of the study. The animals were
housed in a temperature (20–22◦C) and light (12 h light − 12 h
dark cycle) controlled animal facility.
Compound and Treatment
THP (N-trimethyl-hydrazine-3-propionate) was prepared
by ReseaChem GmbH (Burgdorf, Switzerland) as described
previously (Spaniol et al., 2001). After 1 week of acclimatization,
24 rats were randomly divided into two groups as follows: (1)
animals treated with water (CTL, n = 12); (2) animals treated
with THP (20mg × 100 g−1 body weight × day−1 for 21 days)
(THP; n = 12). THP was dissolved in water and the animals
were treated for 3 weeks by oral gavage. Half of the animals of
each group performed an exhaustive exercise before sacrifice.
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Water was provided ad libitum throughout the study. Food
consumption and changes in body weight were examined every
3 days (Figures 1A,B). Based upon the findings of our previous
study, the rats received a standard chow (Kliba Futter 3433,
Basel, Switzerland) ad libitum (carnitine content 16.9 nmol ×
g−1), as the effect of carnitine-deficient food upon carnitine
homeostasis is minor in rats treated with THP (Spaniol et al.,
2001).
Treadmill Exercise
After 3 weeks of treatment, the rats were submitted to an
exhaustive exercise on a treadmill with previous acclimatization
to the apparatus (Treadmill Control, Panlab R©, Barcelona, Spain).
Two days before the sacrifice, rats were accustomed to the
treadmill in a daily session of 5-min training at a speed of 40 cm
× s−1 with a slope of +5◦. On the day of sacrifice, the starting
speed was 40 cm × s−1 with a slope of +5◦; after 40min, the
speed was increased by 5 cm × s−1 every 2min until exhaustion
(Bouitbir et al., 2011). The rear of the treadmill was equipped
with low-voltage, electric stimulating grids, to encourage the
rats to run. The grid delivered 0.4mA at a frequency of 2Hz,
which caused an uncomfortable shock but without injuring the
animal. Exhaustion was defined as immobility for more than 5 s
on the end lane grid despite electric stimulation (Bouitbir et al.,
2011). Blood lactate concentrations were determined in a sample
collected from the tip of the tail before, immediately after and
15min after exercise using a lactate pro-LT device (Lactate Pro
LT-1710, ARKRAY R©).
Vertical mechanical work and power of the exercise session
were calculated according to Isner-Horobeti et al. (2014):
Vertical mechanical work (J) = height×m× g (1)
Vertical mechanical power (W) = vertical mechanical work/t
(2)
Where: J = Joule; W = Watt; t = running time in s; height
in meter calculated with the Pythagorean theorem; m = animal
body weight in kg, and g= gravitational constant in m× s−2.
Biological Sample Collection
After exhaustion, the rats were anesthetized with an
intraperitoneal application of ketamine (160mg × kg−1) and
xylazine (20mg× kg−1). The soleus (oxidative muscle composed
predominantly with type I fibers), and the superficial part of the
gastrocnemius (glycolytic muscle composed predominantly with
type II fibers) were excised and conserved in ice-cold BIOPS
buffer (10mM Ca-EGTA buffer, 0.1µM free calcium, 5.77mM
ATP, 6.56mM MgCl2, 20mM taurine, 15mM phosphocreatine,
0.5mM dithiothreitol, and 50mMK-MES, pH 7.1) until analysis.
A part of the muscle samples was frozen in liquid nitrogen
immediately after excision for further analysis.
Blood was obtained by intracardiac puncture or tail incision
and collected into heparin-coated tubes. Plasma was separated by
centrifugation at 3000 g for 15min. Plasma and muscle samples
were kept at−80◦C until analysis.
FIGURE 1 | Characterization of the animals. (A) Evolution of body weight during the treatment. (B) Plasma total and free carnitine in rats treated or not with THP.
(C) Soleus and (D) gastrocnemius weight relative to the body weight. Data are represented as mean ± SEM of 6 animals per group. **p < 0.01 and ***p < 0.01
compared to CTL group.
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Plasma Parameters
Creatine kinase activity in plasma was determined before and
after exhaustive exercise with a kit according to the supplier’s
instructions (BioAssay Systems, Hayward, CA, USA). Free and
total carnitine concentrations were determined as described
previously (Morand et al., 2013).
High-Resolution Measurement of
Mitochondrial Respiration
Mitochondrial respiration measured in situ allows the
characterization of functional mitochondria in their normal
intracellular position and assembly, preserving essential
interactions with other organelles. Mitochondrial oxygen
consumption was studied in saponin-skinned fibers (Kuznetsov
et al., 2008). Fibers were separated under a binocular microscope
in BIOPS buffer at 4◦C. After dissection, fibers were transferred
into relaxing BIOPS buffer containing 50µg × mL−1 saponin
and incubated at 4◦C for 30min while shaking to complete
permeabilization of the sarcolemma. Permeabilized fibers
were then washed in BIOPS buffer for 10min under intense
shaking to completely remove saponin. Before oxygraphic
measurements, the fibers were washed twice for 5min in MiR05
buffer (EGTA 0.5mM, MgCl2 3mM, taurine 20mM, KH2PO4
10mM, HEPES 20mM, D-sucrose 110mM, BSA essentially
fatty acid free 1 g/L, and lactobionic acid 60mM) to remove
any traces of high-energy phosphates. All oxygen measurements
were performed at 37◦C with an Oxygraph 2k apparatus
equipped with the Datlab software (OROBOROS, Innsbruck,
Austria).
Wet weight of the fibers (2–3mg) was determined after
permeabilization, which reduces osmotic variations of the water
content as described (Pesta and Gnaiger, 2012).
Loosely connected fiber bundles were placed for 5 s onto dry
filter paper. During this time period, we wiped off any liquid from
the tip of the forceps with another filter paper. Then, we took
the sample from the filter paper by a forceps and removed any
trace of water on the surface on a dry area of the filter paper
before weighing the sample. Immediately weight recording, the
sample was transferred into 2.0mL of MiR05 buffer and analyzed
by high-resolution oximetry.
The rate of basal respiration was measured with the complex
I substrates glutamate (10mM) and malate (2mM), before state
3 respiration was induced with ADP (2mM). Since oxygen
is the electron acceptor, enzyme complexes I, III and IV are
used under these conditions. After inhibition of complex I
with rotenone (0.5µM), respiration was restored with addition
of the complex II substrate succinate (10mM). Under these
conditions, enzyme complexes II, III, and IV were assessed.
To verify the integrity of the outer mitochondrial membrane,
cytochrome c (10µM) was added. Inhibition of complex III with
antimycin (2.5µM) was followed by the addition of artificial
substrates for complex IV, TMPD (0.5mM) and ascorbate
(2mM).We performed the experiments in duplicate. Respiration
rates are expressed in picomoles O2 × s
−1 × mg−1 wet
weight.
Activity of Individual Enzyme Complexes of
the Electron Transport Chain
Spectrophotometric analysis of the activity of individual enzyme
complexes was performed as described by Spinazzi et al. (2012).
In brief, frozenmuscle samples were thawed and homogenized in
water.
Complex I+ III assay was performed in an assay mixture
composed of (final concentrations) 50mM potassium phosphate,
1 g/L BSA, 0.3mM KCN, 50µM ferricytochrome c, and 0.5mM
reduced nicotinamide adenine dinucleotide (NADH), pH 7.4.
The increase in absorbance was followed at 550 nm. The
rotenone-sensitive complex I+ III activity was determined by
subtracting the activity of identical wells containing in addition
1µM rotenone.
Complex II activity was measured in an assay mixture
containing (final concentrations) 50mM potassium phosphate,
1 g/L BSA, 0.1mM Na2EDTA, 3.75mM sodium azide, 0.3mM
KCN, 20mM succinate, 100µM dichlorophenolindophenol
(DCIP), pH 7.2. Changes in absorbance were followed at 600 nm.
Malonate sensitive activity was calculated by subtracting the
activity of identical wells containing 10mMmalonate.
Complex IV activity was measured in an assay buffer
containing (final concentrations) 50mM potassium phosphate
and 17µM of freshly prepared ferrocytochrome c, pH 7.4.
Changes in absorbance were followed at 550 nm. Specific
complex IV was calculated by subtracting the activity of identical
wells containing 0.3mM KCN.
Complex activities were determined on a Tecan M200 Pro
Infinity plate reader (Männedorf, Switzerland) using a 96-well
plate. Values were normalized to citrate synthase activity.
Citrate Synthase (CS) Activity
Pieces of frozen muscle (5–10mg wet weight) were homogenized
with a vibrating microbead homogenizer (Mikro-Dismembrator,
Sartorius R©, Palaiseau, France) in a ratio (W/V) of 1/20 with a
buffer containing 5mM HEPES, 1mM EGTA and 1mM DTT,
pH 8.7. The homogenate was then supplemented with 0.1%
Triton X-100 and incubated on ice for 1 h. After centrifugation
for 5min at 3000 rpm, CS activity was determined in the
supernatant by spectrophotometry (Tecan M200 Pro Infinity
plate reader, Männedorf, Switzerland) using a 96-well plate as
described by (Srere, 1969). Values were reported in µmol ×
min−1 × g−1 of wet weight.
H2O2 Production Rates in Permeabilized
Muscle Fibers
Mitochondrial H2O2 production rates by permeabilized muscle
fibers were determined as described previously using Amplex
Red reagent (Invitrogen, Switzerland; Anderson and Neufer,
2006). Change in fluorescence per second (1F) was measured
continuously with a spectrofluorometer (Fluoromax 4 Jobin
Yvon R©, Edison, New Jersey, USA). First, background 1F
(reactants only) was established before the reaction was initiated
by addition of 2–3mg permeabilized muscle fibers (from soleus
or gastrocnemius to 600µl of buffer Z containing K-methane
sulfonate 110mM, KCl 35mM, EGTA 1mM, K2HPO4 10mM,
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and MgCl2 3mM with Amplex Red 5µM and horseradish
peroxidase 0.3U/ml (Invitrogen, Switzerland). The following
additions were then made sequentially: the complex I substrate
glutamate-malate (5 and 2.5mM, respectively), the complex II
substrate succinate (5mM), the complex I blocker rotenone
(0.5µM) and the complex III blocker antimycin A (2.5µM).
The rates of H2O2 production were calculated using
a standard curve established with the same experimental
conditions, except that fibers were absent. The background
activity was subtracted from the activity obtained in the presence
muscle fibers. H2O2 measurements were expressed in pmoles ×
min−1×mg−1 wet weight.
Mitochondrial Free Radical Leak (FRL)
H2O2 production and O2 consumption were measured
simultaneously in the same sample in the presence of glutamate
+malate, rotenone, succinate, and ADP allowing to quantify the
parameter under respiration supported by the complex II donor
succinate under state 3 conditions. This allowed the calculation
of the fraction of electrons out of sequence, which reduce O2 to
ROS in the respiratory chain (the percentage of free radical leak)
instead of reaching cytochrome oxidase to reduce O2 to water.
Because two electrons are needed to reduce one mole of O2 to
H2O2, whereas four electrons are transferred in the reduction
of one mole of O2 to water, the percent of FRL was calculated
according to Anderson and Neufer (2006) as the rate of H2O2
production divided by twice the rate of O2 consumption, and
then the result was multiplied by a factor of 100.
Tissue GSH Content
The GSH (reduced glutathione) content was determined
using the luminescent GSH-Glo Glutathione assay (Promega,
Wallisellen, Switzerland) according to the manufacture’s manual.
In brief, muscle tissue (10mg) was homogenized in 1mL PBS
with 2mM EDTA with a Mikro-Dismembrator for 1min at
3000 rpm (Sartorius Stedim Biotech, Göttingen, Germany). After
centrifugation, 50µL supernatant was added to 50µl GSH-Glo
Reagent in a 96-well plate and incubated for 30min. Afterwards,
100µl Luciferin Detection Reagent was added to each well and
the luminescence was measured after 15min using a TecanM200
Pro Infinity plate reader (Männedorf, Switzerland). The GSH
standard curve was performed and the results were expressed in
µmol× g−1 of wet weight
Muscle Parameters
Muscle tissue (50mg) was homogenized with a Mikro-
Dismembrator for 1min at 2000 rpm (Sartorius Stedim Biotech,
Göttingen, Germany). Muscle glycogen content was analyzed in
alkaline (NaOH 0.1mM) muscle extracts according to Harris
et al. (1974). The lactate content was analyzed according to Olsen
(1971).
Quantitative Real-Time Polymerase Chain
Reaction (q-RT-PCR)
Total RNA was extracted from muscle using a commercially
available TRIzol Reagent kit (Invitrogen, Basel, Switzerland).
Briefly, 50mg of muscle were removed from the freezer and
immediately immersed in 1ml of TRIzol reagent. The aqueous
and organic phases were separated using 200µl of chloroform.
Total RNA was precipitated using 600µl of isopropyl alcohol,
washed twice with ethanol, redissolved in RNAse free H2O
and stored at −80◦C. The concentration and purity of the
RNA were determined using a Nanodrop (Thermo Scientific,
Wohlen, Switzerland) by measuring the absorbance at 260 and
280 nm. The reverse transcription (RT) was performed on 1µg
of total RNA using a commercially available kit (Invitrogen,
Life Technologies, Switzerland). RT was performed in a thermal
cycler with a profile of 65◦C for 5min, 42◦C for 50min, and
72◦C for 15min. All samples were run together. Following RT,
samples were stored at −20◦C until analysis. Real—time PCR
measurement of individual cDNAs was performed in triplicate
using SYBR green dye (Roche Diagnostics, Rotkreuz, Basel)
containing 10µM of each primer (sense and antisense). Primer
sequences were designed using information contained in the
public database in the GeneBank of the National Center for
Biotechnology Information. The sequences of primer sets used
are listed in Table 1. Amplification efficiency of each sample was
calculated as previously described (Ramakers et al., 2003), and
relativemRNA expression levels were calculated using the11CT
method with beta actin gene as internal control.
Mitochondrial DNA Content
To measure the mitochondrial DNA content, we determined
the ratio of one mitochondrial gene to a nuclear gene using
quantitative real-time RT-PCR as described previously with
some modifications (Pieters et al., 2013). Total DNA was
extracted using the DNeasy Blood and Tissue Kit (Qiagen)
following the manufacturer’s instructions (Quick-Start Protocol).
The concentration of the extracted DNA was measured
spectrophotometrically at 260 nm with the NanoDrop 2000
(Thermo Scientific, Wohlen, Switzerland). Afterwards, DNA was
diluted in RNase free water to a final concentration of 10 ng
× µL−1. The analysis of the mitochondrial cytochrome b and
the nuclear pyruvate kinase genes purchased from Microsynth
(Balgach, Switzerland) was performed using SYBR Green real-
time PCR (Roche Diagnostics, Rotkreuz, Switzerland) on an
ABI PRISM 7700 sequence detector (PE Biosystems, Rotkreuz,
Switzerland). Relative amounts of nuclear and mitochondrial
DNA were determined by comparison of the amplified and
quantified DNA from pyruvate kinase and cytochrome b (Primer
sequences in Table 1). The amount of mitochondrial DNA was
also normalized to citrate synthase activity.
Statistical Analysis
Data is expressed as mean ± SEM. Comparisons of two groups
were performed using the unpaired two-tailed Student’s t-test.
Multiple groups were compared using one-way ANOVA followed
by a Tukey post-test. The software used was Prism version 6
(Graph Pad Software, San Diego, CA). Statistical significance was
set at ∗p < 0.05.
RESULTS
Animal Data
As shown in Figure 1A, the bodymass was similar between THP-
treated and CTL rats during the 21 days of chow feeding. Each
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TABLE 1 | Primer sequences used for quantitative Real-Time PCR
amplification.
Target gene Forward primer 5′ −→3′ Accession number
Reverse primer 5′ −→3′
PGC-1α GCTGGACACTGGACTTCCTC NC 005100
GAGGACTCCAGCCACAAAGA
PGC-1β CGACTTTGCAGAGATGTCCA NC 005112
CCTGAAGAGTTCCTCCACCA
TFAm GAAAGCACAAATCAAGAGGAG NM 031326
CTGCTTTTCATCATGAGACAG
SOD1 AGATGACTTGGGCAAAGGTG NM 017051
CAATCCCAATCACACCACAA
SOD2 CTGGACAAACCTGAGCCCTA NM 017051
GAACCTTGGACTCCCACAGA
Beta actin TTGCTGACAGGATGCAGAAG BC 166732
CAGTGAGGCCAGGATAGAGC
Cyt b GCAGCTTAACATTCCGCCCAATCA J01436
TACTGGTTGGCCTCCGATTCATGT
Pyruvate kinase TGTGGGTGATCTGGTGATTGTGGT NM 012624
AGGCATTTCAGGATACGCTCAGCA
group linearly gained∼80 g body weight during the course of the
study. Daily food consumption was also not different between the
CTL and THP-treated rats (data not shown). The total carnitine
concentration was 7.5 ± 0.9 and 55.7 ± 2.8µmol × L−1 and
the plasma free carnitine concentration 4.7 ± 0.6 and 35.9 ±
1.6µmol × L−1 in THP-treated and control rats, respectively
(Figure 1B).
Skeletal Muscle Weights
The absolute muscle weight of tendon-to-tendon excised
oxidative soleus muscle was reduced by 24% in the THP-treated
when compared to CTL rats (143± 6 vs. 187± 7mg wet muscle;
p < 0.01; data not shown). This decrease in muscle weight was
maintained when the soleus weight was expressed relative to the
body weight (Figure 1C). In contrast, no significant reduction in
absolute weight (1780± 60 vs. 1970± 60mg wet muscle in THP-
treated and CTL rats, respectively; data not shown) or muscle
weight relative to body weight (Figure 1D) was observed for the
mainly glycolytic gastrocnemius muscle of THP-treated vs. CTL
rats.
Exhaustive Exercise
We performed an exhaustive treadmill exercise in a subgroup
of THP-treated and CTL rats. As shown in Figure 2A, the
distance that was covered by animals treated with THP was
lower compared to the untreated animals (−39%; p < 0.05;
Figure 2A). Since the animals should have covered 960m during
the first 40min (speed of the treadmill 40 cm × s−1), the data
show that the majority of the animals of both groups were
exhausted already before 40min (before increasing the speed
of the treadmill). When we calculated the vertical mechanical
power of the animals, we observed a significant decrease in the
THP group compared to the CTL group (−42%; p < 0.05;
Figure 2B).
Energy Metabolism Parameters in Plasma
and Skeletal Muscle at Rest and after
Exhaustive Exercise
As shown in Figure 2C, the plasma lactate concentrations
increased significantly with exercise in both treatment groups,
indicating that the rats exercised above the lactate threshold.
The plasma lactate concentration immediately after exercise
was significantly higher in the THP compared to the control
group (p < 0.05). After 15min of recovery, the plasma
lactate concentration had almost reached pre-exercise values in
both treatment groups without a significant difference between
the groups. As expected, the plasma creatine kinase activity
increased significantly in both THP-treated and CTL rats with
exercise (Figure 2D). After exercise, the plasma creatine kinase
activity was significantly higher in THP-treated as compared to
CTL rats.
Energy Parameters in Skeletal Muscles
Before exercise, the glycogen content was numerically lower
in soleus and gastrocnemius muscle of THP-treated compared
to CTL rats, but without reaching statistical significance
(Figures 3A,B). Exhaustive exercise was associated with a
significant decrease in the glycogen content in soleus and
gastrocnemius muscle of both THP-treated and CTL rats,
but there was no significant difference between the two
groups. The lactate content in soleus significantly increased
in THP-treated and CTL rats with exercise, reaching
significantly higher values for THP-treated compared to
CTL rats (Figure 3C). In the gastrocnemius, the lactate content
increased in both THP-treated and CTL rats with exercise
but without a significant difference between the two groups
(Figure 3D).
High-Resolution Measurement of
Mitochondrial Respiration
In order to find out possible reasons for the reduced
physical performance of THP-treated rats, we determined
the mitochondrial respiration of the electron transport chain in
mitochondria of soleus and gastrocnemius muscle. As shown
in Figure 4, the maximal respiration rate in the soleus muscle,
a red muscle mainly composed of oxidative fibers, was higher
than in the gastrocnemius, which consists mainly of glycolytic
fibers. In the soleus, treatment with THP was associated with
decreased succinate and TMPD/ascorbate-supported respiration,
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FIGURE 2 | Endurance test and plasma analysis. (A) Endurance, evaluated by the average distance run until exhaustion on a treadmill performed in rats treated or
not with THP and (B) vertical mechanical power calculated according the equation described in the methods. (C) Blood lactate concentration before, after and further
15min rest following the exercise (D) blood creatine kinase measured in rats without exercise and after acute exercise in rats treated or not with THP. Data are
represented as mean ± SEM of 6 animals per group. *p < 0.05 and **p < 0.01 compared to CTL group; $p < 0.05 compared to CTL+EX group.
compatible with an impairment of the complexes II and IV, but
possibly also III. In comparison, in gastrocnemius, treatment
with THP was associated with impaired TMPD/ascorbate-
supported respiration (indicating impaired activity of
complex IV), whereas complex I, II and III were not
affected.
Activity of Enzyme Complexes of the
Electron Transport Chain and of Citrate
Synthase
In order to confirm the results obtained by oximetry, we
determined the activity of individual enzyme complexes of
the electron transport chain in homogenate of soleus and
gastrocnemius muscle and related them to the activity of
citrate synthase (Table 2). The activity of citrate synthase, a
marker of the mitochondrial content (Larsen et al., 2012), was
similar in both groups in both muscle types. As shown in
Table 2, treatment with THP was associated with a decrease of
mitochondrial complex II and IV in soleus, whereas the activity of
complex I+ III of the electron transport chain were not affected,
confirming the results obtained by oximetry. In gastrocnemius,
the activities of the enzyme complexes were generally decreased
by treatment with THP, but without reaching statistical
significance.
Taken together the results obtained by oximetry and
spectrophotometry indicate that carnitine deficiency associated
with THP specifically impairs the function of complex II and
IV in the oxidative, and of complex IV in the glycolytic
muscle.
H2O2 Production and Free Radical Leak
Figure 5A shows the results of H2O2 production obtained in
permeabilized fibers from the skeletal muscles in response to
sequential addition of substrates and inhibitors. Net H2O2 release
by fibers was low in the absence of respiratory substrates in
the both treatment groups, but increased by approximately 2-
fold after addition of the complex I substrates glutamate and
malate. In line with previous observations (Anderson andNeufer,
2006), the highest rates of H2O2 release under basal conditions
were observed in the presence of the complex II substrate
succinate. The interruption of normal electron flowwith addition
of the complex I inhibitor rotenone and of the complex III
inhibitor antimycin A was associated a substantial increase in
H2O2 release in both treatment groups. In comparison to CTL
rats, H2O2 production in THP-treated rats was similar under
all states investigated for both soleus and gastrocnemius muscle
(Figures 5A,B).
The free radical leak (FRL), described as a good index for
ROS production (Anderson and Neufer, 2006), was significantly
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FIGURE 3 | Skeletal muscle metabolites at rest and after exercise. Glycogen content measured as described in the methods in (A) soleus and (B)
gastrocnemius muscles from groups. Lactate content measured as described in the methods in (C) soleus and (D) gastrocnemius muscles. Data are represented as
mean ± SEM of 6 animals per group. *p < 0.05 and **p < 0.01 compared to CTL group; $p < 0.05 compared to CTL+EX group.
FIGURE 4 | Respiratory capacity in permeabilized muscle fiber mitochondria. Oxygen consumption was measured in saponin-permeabilized muscle fibers
with glutamate and malate as substrates in (A) soleus and (B) gastrocnemius. Data are represented as mean ± SEM of 5–6 animals per group. *p < 0.05 and
**p < 0.01 compared to CTL group.
higher in the THP group compared to controls in both
muscles in the presence of the complex II substrate succinate
(Figures 5C,D). Interestingly, carnitine deficiency enhanced FRL
in gastrocnemius muscle (+210%, Figure 5D), whereas the
FRL increased robustly in soleus (+309%, Figure 5C) with an
increase significantly higher in soleus muscle compared with
gastrocnemius.
SOD1/SOD2 mRNA Expression Levels and
GSH Pool in Skeletal Muscle
To study the antioxidative defense system, we analyzed the
mRNA content of cytosolic SOD1 and mitochondrial SOD2
by q-RT-PCR as well as the GSH content in soleus and
gastrocnemius muscle. As shown in Figures 6A,B, the SOD1
mRNA expression level was similar in both treatment groups in
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TABLE 2 | Enzymatic activities of mitochondrial electron transport chain complexes.
Soleus Gastrocnemius
CTL THP p-value CTL THP p-value
Complex I+ III (relative to CS) 0.020±0.005 0.020± 0.006 0.966 0.10± 0.02 0.078± 0.032 0.561
Complex II (relative to CS) 0.484±0.072 0.166± 0.068 0.012 0.218± 0.032 0.112± 0.040 0.076
Complex IV (relative to CS) 2.43±0.20 1.39± 0.26 0.032 0.197± 0.048 0.176± 0.045 0.751
Citrate synthase (µmol × min−1 × g−1) 39.1±1.5 40.4± 1.4 0.559 12.7± 2.1 17.1± 3.5 0.294
Values are expressed as mean ± SEM of 5–6 animals per group for three independent experiments.
both muscles. Interestingly, the SOD2 mRNA expression level
was increased in soleus of THP-treated as compared to CTL
rats, reaching borderline significance (Figure 6A; p = 0.057).
In gastrocnemius, the SOD2 mRNA expression level was also
numerically higher in the THP-group compared to the CTL
group (Figure 6B; p = 0.0794). The GSH content, which is an
important defense against ROS accumulation, was decreased in
soleus muscle of THP-treated compared to CTL rats (Figure 6C;
p < 0.05) but was similar between the treatment groups
in gastrocnemius (Figure 6D). Since we did not determine
oxidized glutathione (GSSG), this finding could be explained
by both increased oxidation of GSH and/or impaired GSH
biosynthesis.
Mitochondrial Biogenesis and Content
Impaired physical performance in THP-treated rats could
not only be a consequence of mitochondrial damage, but
also of an impaired mitochondrial biogenesis. We therefore
determined PGC-1α and PGC-1β mRNA expression levels,
both important transcriptional co-activators of numerous
genes coding for mitochondrial proteins. mRNA expression
of PGC-1α and PGC-1β were lower in the soleus of THP-
treated than CTL rats (p < 0.01 and p < 0.05,
respectively; Figure 7A). Consequently, mitochondrial TFAm
mRNA expression, which regulates the amount of mtDNA, was
also lower in THP-treated compared to the CTL rats (p <
0.05; Figure 7A). In contrast, in the gastrocnemius, PGC-1β
mRNA expression was increased in THP-treated compared to
CTL rats (p < 0.05; Figure 7B), whereas the mRNA expression
of PGC-1α and of TFAm were not different between the two
groups.
In soleus muscle, in agreement with the mRNA expression
of PGC-1α and PGC-1β, both the amount of mitochondrial
DNA expressed per nuclear DNA (p < 0.05; Figure 7C)
and per citrate synthase activity (p < 0.05; Figure 7E)
was decreased in THP-treated compared to control rats.
In comparison, in gastrocnemius muscle, the mitochondrial
DNA content was not affected by treatment with THP
(Figures 7D,F).
DISCUSSION
The present investigation enlarges our knowledge about the
consequences of carnitine depletion due to treatment with THP
on exercise performance and mitochondrial function in different
types of skeletal muscle in rats. First, we showed that the THP-
induced decrease of the muscle carnitine content is associated
with impaired exercise capacity. Second, treatment with THPwas
associated with a marked atrophy of the oxidative soleus muscle
as well as with impaired activity of complex II and IV of the
electron transport chain, a decrease in the cellular glutathione
pool, a decrease in the mRNA expression of regulators of
mitochondrial biogenesis, and reduced mitochondrial DNA
content compared to control rats. In comparison, in the glycolytic
gastrocnemius muscle, THP treatment was associated with only
a decrease of complex IV activity, whilst the cellular glutathione
pool and the mitochondrial DNA content were not affected
compared to control muscle.
In our previous studies, we have shown repeatedly that
treatment with THP for 21 days is associated with a 70–80%
decrease in the skeletal muscle carnitine content (Spaniol et al.,
2001; Zaugg et al., 2003; Roberts et al., 2015). Since we
observed a 86% reduction in the plasma total and free carnitine
concentrations in THP-treated compared to control rats, and
since we reproduced the effect of treatment with THP on the
skeletal muscle carnitine pool several times (Spaniol et al., 2001),
we did not determine the skeletal muscle carnitine content in
the current study. The THP-associated decrease in the skeletal
muscle carnitine pool is comparable to the decrease observed in
jvs−/− mice (Higashi et al., 2001) or also to humans suffering
from primary carnitine deficiency (Shapira et al., 1993).
Effect of Carnitine Depletion on Exercise
Capacity
The evaluation of the exercise capacity showed that both the
distance covered until exhaustion and vertical mechanical work
were reduced in THP-treated rats. Regarding skeletal muscle
performance, carnitine has two main functions. First, it is an
obligatory intermediate for the transport of long-chain fatty acids
across this inner mitochondrial membrane (Fritz and Mc, 1959;
Bremer, 1983) and, second, carnitine stimulates the activity of
pyruvate dehydrogenase (Wall et al., 2011) by buffering the
mitochondrial CoASH pool (Brass and Hoppel, 1980; Friolet
et al., 1994). As indicated by the increased lactate blood and
skeletal muscle concentrations and by the reduced skeletal
muscle glycogen stores, rats exercised above the lactate threshold
during the physical performance experiment, suggesting that
mainly glucose and to a minor extent fatty acids have been the
main fuel for skeletal muscle under these conditions (Gollnick
et al., 1974; Roberts et al., 1996). It can therefore be assumed
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FIGURE 5 | Mitochondrial H2O2 production and Free Radical Leak. H2O2 release measured with Amplex Red from permeabilized fibers of (A) soleus and (B)
gastrocnemius and calculated from the slope of change in fluorescence in fibers from rats treated with THP and control rats. FRL calculated as described in the
methods for (C) soleus and (D) gastrocnemius. Data are represented as mean ± SEM of 6 animals per group. *p < 0.05 compared to CTL group.
FIGURE 6 | SOD1/SOD2 mRNA expression and cellular GSH content. mRNA expression levels of cytosolic SOD1 and mitochondrial SOD2 relative to beta-actin
and normalized to control values by q-RT-PCR in (A) soleus muscle and (B) gastrocnemius muscle of both groups. Reduced GSH was measured in (C) soleus muscle
and (D) gastrocnemius muscle of both groups. Data are represented as mean ± SEM of 6 animals per group. *p < 0.05 compared to CTL group.
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FIGURE 7 | Mitochondrial biogenesis and DNA content. mRNA expression of PGC-1α, PGC-1β, and TFAm relative to control values measured by q-RT-PCR in
(A) soleus and (B) gastrocnemius. Mitochondrial to nuclear DNA content of (C) soleus and (D) gastrocnemius muscle normalized to control values. Mitochondrial DNA
content expressed per citrate synthase activity of (E) soleus and (F) gastrocnemius muscle normalized to control values. Data are represented as mean ± SEM of 6
animals per group. *p < 0.05 and **p < 0.01 compared to CTL group.
that the effects of carnitine on glucose metabolism have been
more important in the current situation than those on fatty
acid metabolism. Accordingly, the observed decrease in physical
performance is probably mainly due to an impaired function
of glycolytic and to a minor extent of oxidative muscles. In
a previous study using the same animal model of carnitine
deficiency, we have indeed shown in in vitro experiments
that the maximal contraction of the mainly glycolytic extensor
digitorum longus (EDL)muscle is impaired (Roberts et al., 2015).
This observation fits well with the current findings. The most
probable explanation for this finding was a marked decrease
in the EDL muscle free CoA content in rats treated with
THP, leading to a reduced flux through pyruvate dehydrogenase
(Roberts et al., 2015). In the current studies, we additionally
found a significant impairment in the activity of complex IV
in the gastrocnemius muscle of THP treated rats, offering
an additional explanation regarding the observed reduction in
exercise capacity. Furthermore, we found an increased free
radical leak, possibly as a consequence of the impaired activity
of the mitochondrial electron transport chain (Balaban et al.,
2005). The cellular glutathione content was not affected in
gastrocnemius muscle of THP-treated rats, suggesting that the
increase of the free radical leak was not large enough to impair
the antioxidative defense system.
Effect of Carnitine Depletion on Oxidative
Skeletal Muscle
In comparison to the glycolytic gastrocnemius muscle, the
effects of carnitine depletion were more pronounced on the
oxidative soleus muscle. Nevertheless, as discussed above, these
findings may contribute, but cannot entirely explain the observed
decrease in exercise performance in THP-treated rats, since
the rats were exercising above the lactate threshold. Similar
to the gastrocnemius, carnitine depletion was associated with
increased lactate content after exercise in the soleus muscle.
Since, in our previous study (Roberts et al., 2015), the free
CoA content was only numerically decreased and the ex vivo
pyruvate dehydrogenase activity maintained in soleus muscle of
THP-treated rats, this finding is explained best by the observed
impairment of complex II and IV of the electron transport
chain, which was more pronounced in the oxidative soleus
compared to the glycolytic gastrocnemius muscle. Impaired
activity of the electron transport chain is associated with
an increase in the mitochondrial NADH/NAD ratio, which
could in vivo impair the activity of pyruvate dehydrogenase
(Patel et al., 2014). Similar to the gastrocnemius muscle, we
observed an increase in ROS production relative to oxygen
used (increased free radical leak), which was associated with
an increase in the mRNA expression of SOD2 and with a
decrease in the cellular GSH content. A possible interpretation
of these findings is that the ROS production in soleus muscle
was high enough to reduce the cellular glutathione pool
and to induce SOD2 mRNA expression. Increased mRNA
expression of SOD2 as a consequence of enhanced ROS
production has been described previously (Kensler et al.,
2007; Felser et al., 2013). Since carnitine has been described
to possess antioxidative properties (Gülçin, 2006), carnitine
deficiency could decrease the antioxidative capacity, leading to
oxidative stress already at normally tolerated ROS production
levels.
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Increased ROS production has been described not only to
up-regulate the antioxidative defense system including the Nrf2
pathway, and SOD2 (Kensler et al., 2007), but also to stimulate
mitochondrial proliferation (Piantadosi and Suliman, 2012).
Accordingly, in the gastrocnemius muscle, the mRNA expression
of mitochondrial proliferation regulators (PGC-1α, PGC-1β,
TFAm) was numerically increased, with PGC-1β reaching
statistical significance. This increase in the mRNA expression of
mitochondrial proliferation regulators did, however, not translate
into a significant increase in mtDNA. In contrast, in the oxidative
soleus muscle, which is rich in mitochondria, mRNA expression
of the above mentioned regulators of mitochondrial proliferation
was significantly decreased in THP-treated rats with a consequent
significant decrease in the mtDNA related to nuclear DNA or
citrate synthase activity. The reasons for the different reaction
of the oxidative soleus vs. the glycolytic gastrocnemius muscle
to carnitine depletion are currently not clear, but may be related
to the more accentuated mitochondrial damage and to muscle
atrophy that we observed in soleus muscle in the current as well
as in our previous study (Roberts et al., 2015). In our previous
study, we could demonstrate that soleus muscle atrophy in THP-
treated rats is a consequence of apoptosis, which is triggeredmost
likely by mitochondrial dysfunction (Roberts et al., 2015).
CONCLUSIONS
The current study showed that the THP-induced carnitine
deficiency was associated with a decreased physical performance
in rats exercising above the lactate threshold. Carnitine depletion
affected oxidative and glycolytic muscles differently. In the
oxidative soleus, we found muscle atrophy and reduced activity
of complex II and IV of the electron transport chain with
a concomitant increase in ROS production and alterations
in the antioxidative defense system. mRNA expression of
mitochondrial proliferation markers and mtDNA were reduced.
In comparison, in the glycolytic gastrocnemius, muscle mass
was not decreased, only complex IV of the electron transport
chain was impaired and the oxidative defense system as well
as the mtDNA content were not affected. Taking into account
that glucose is the main fuel for muscle work above the
lactate threshold, the observed decrease in physical performance
of THP-treated rats can be explained by an impaired buffer
function of carnitine regarding free CoASH and by the
observed mitochondrial dysfunction in glycolytic and oxidative
muscles.
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